Physician profile
Stephen A Rosenberg
NPI 1932441656
$17,935.79
in general payments reported to CMS, 2019-2025
6 companies · $14.25 in 2025
The $14.25 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2020: $2,500 · 2021: $259 · 2022: $9,686 · 2023: $3,701 · 2024: $277 · 2025: $14.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,240 · Food and Beverage: $890 · Travel and Lodging: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,240.00 |
| Food and Beverage | $890.15 |
| Travel and Lodging | $861.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $9,621.44 | 2019-2023 | Optune |
| Viewray Technologies INC | $4,163.01 | 2021-2022 | |
| Novocure Gmbh | $2,400.00 | 2022 | |
| Elekta, INC. | $1,488.03 | 2023-2024 | Elekta Unity, Elekta Medical Linear Accelerator |
| Ge Healthcare | $249.06 | 2023 | |
| Leo Pharma INC. | $14.25 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.